Growth of IDH1 mutant cancers can be decoupled from 2-hydroxyglutarate levels
Mutant IDH1 decreases NAD+ levels by inhibiting an alternate NAD+ salvage pathway
Depletion of NAD+ is strikingly potent and specific for IDH1 mutant cancers
NAD+ depletion induces autophagy by activating intracellular energy sensors